DTIL Precision BioSciences Inc.: שווי החברה בספרים

Precision BioSciences (DTIL) automates genome editing via ARCUS AI systems, eliminating routine tasks for researchers. This daily price chart reflects a level of 0.05. The business relies on exclusive software for combating genetic pathologies, secured through partnerships with industry behemoths. High human capital potential is ensured by attracting top biologists, who are guaranteed competitive compensation and development budgets.

For Precision BioSciences (DTIL), which monetizes its ARCUS platform through licensing fees from pharma behemoths, the company's accounting capitalization history reflects the actual dynamics of accumulated net assets. This indicator is calculated as the difference between all assets and liabilities, serving as a fundamental filter against market overvaluations and allowing investors to assess the intrinsic value of the business independently of speculative optimism in share prices.